SavedAdd your journal

Journals / Van Tıp Dergisi / 2014 / Cilt: 21 - Sayı: 3

Comparasion of the efficacy of smoking cessation therapies after earthquake

Deprem sonrası sigara bırakma tedavilerinin etkinliklerinin karşılaştırılması

Selami EKİN
HÜLYA GÜNBATAR
Bünyamin SERTOĞULLARINDAN
AHMET ARISOY
HANİFİ YILDIZ
Ali EMAN
Haci Yusuf GÜNEŞ
Pages
139–142
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Result: In cases of natural disaster such as an earthquake, drug efficacies are less than the normal population, and disasters in drug activities, active and effective smoking cessation clinics concluded functions should continue.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The most important cause of preventable morbidity and mortality is smoking.
📊
Key Findings & Data:Patients ongoing drug therapy for 3 months or patients who could be contacted by phone controls were included in the study. 274 patients were included in the study. 70.4% of patients (n = 193) were male and 29.6% (n = 81) were female. 151 people were included in varenicline group, and 123 people in bupropion group.
💡
Conclusion & Impact:Result: In cases of natural disaster such as an earthquake, drug efficacies are less than the normal population, and disasters in drug activities, active and effective smoking cessation clinics concluded functions should continue.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The most important cause of preventable morbidity and mortality is smoking. Seventeen milion persons smoke in Turkey and every year one hundred thousand people die due to smoking releated disease. Materials and Methods: Patients who were started varenicline or bupropion after admission to smoking cessation treatment were retrospectively evaluated in terms of smoking cessation success. Patients ongoing drug therapy for 3 months or patients who could be contacted by phone controls were included in the study. 274 patients were included in the study. 70.4% of patients (n = 193) were male and 29.6% (n = 81) were female. 151 people were included in varenicline group, and 123 people in bupropion group. No significant difference was found between Varenicline and bupropion for smoking cessation in patients. Result: In cases of natural disaster such as an earthquake, drug efficacies are less than the normal population, and disasters in drug activities, active and effective smoking cessation clinics concluded functions should continue.

Özet

Amaç: Sigara içimi önlenebilir morbidite ve mortalitenin en önemli nedenidir. On yedi milyon kişinin sigara tüketicisi olduğu ülkemizde, her yıl 100 bin kişi sigaraya bağlı hastalıklardan dolayı yaşamını yitirmektedir. Gereç ve Yöntem: Sigara bırakma polikliniğine başvuran, vareniklin veya bupropion tedavisi başlanmış olan hastaların, sigarayı bırakma başarılarını retrospektif olarak incelemeyi amaçladık. 3 ay boyunca ilaç tedavileri devam eden ve kontrollere gelen veya telefon ile ulaşılabilen hastalar çalışmaya dâhil edildi. Çalışmaya 274 olgu alındı. Olguların %70,4 (n:193) erkek, %29,6 (n:81) kadın idi. Vareniklin alan grup 151 kişi, bupropion alan 123 kişi idi. Sonuç: Vareniklin ve bupropion alan olgular arasında sigarayı bırakma açısından anlamlı fark saptanmadı. Deprem gibi doğal afet durumlarında, normal topluma göre ilaç etkinliklerinin daha az olduğu ve afetlerde de sigara bırakma polikliniklerinin aktif ve etkili biçimde işlevlerine devam etmesi gerektiği kanaatine varıldı.

🔖

Cite This Article

EKİN, S., GÜNBATAR, H., SERTOĞULLARINDAN, B., ARISOY, A., YILDIZ, H., EMAN, A., GÜNEŞ, H. Y. (2014). Comparasion of the efficacy of smoking cessation therapies after earthquake. Van Tıp Dergisi, Cilt: 21 - Sayı: 3, 139–142. https://ajindex.com/articles/334156

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. WHO tobacco free initiative. Building blocks for tobacco control: a handbook Geneva witzerland: World WHO organization 2004
  2. Mathers CD, Loncar D. Projection of global mortality and burden of disease from 2002 to 2030 Plos Med 2006; 3: e442
  3. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer 2005; 116(6):963-971
  4. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55(12):987-999
  5. Office for National Statistics. Smoking-related behaviour and attitudes. 2008. www.statistics.gov.uk /downloads/theme_health/ Smoking2005.pdf
  6. West R, Sohal T. "Catastrophic" pathways to smoking cessation: findings from national survey. BMJ 2006; 332(7539):458-460
  7. McEwen A, West R. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services. BMC Public Health 2009; 9:28
  8. Uzaslan EK, Özyardımcı N, Karadag M, Yüksel EG. The physician’s intervention in smoking cessation: Results of the five years of smoking cessation clinic. Ann Med Sci 2000; 9: 63-69
  9. Onen ZP, Sen E, Eriş Gülbay B, Oztürk A, Akkoca Yıldız O, Acıcan T, ve ark. [Comparing the effectiveness of different treatment modalities on the smoking cessation rates]. [Article in Turkish] Tuberk Toraks 2010; 58(4):385-392
  10. Solak ZA, Telli CG, Erdinç E. Sigarayı bırakma tedavisinin sonuçları. Toraks Dergisi 2003; 4:73-77
  11. Salepçi B, Fidan A, Oruç Ö, Torun E, Çağlayan B, Kader Ş. Sigara bırakma polikliniğimizde başarı oranları ve başarıda etkili faktörler. Toraks Dergisi 2005; 6:151-158
  12. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309(6958):842-846
  13. Can G, Oztuna F, Ozlü T. [The evaluation of Outpatient Smoking Cessation Clinic results]. [Article in Turkish] Tuberk Toraks 2004; 52(1):63-74.